CompletedNot Applicable

Uterotonics for Severe Preeclampsia

Egypt124 participantsStarted 2020-01-01

Plain-language summary

The study compares the effect of Intravenous carbetocin versus combined use of intravenous oxytocin and rectal misoprostol for prevention of postpartum hemorrhage during delivery of women with severe preeclampsia

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pregnant women which diagnosed with severe pre-eclampsia. * Singleton pregnancy. * Termination of pregnancy by Cesarean section after 28 weeks of gestation. Exclusion Criteria: * Suspected or proven placental abruption. * Known placenta Previa or acreata. * Multiple pregnancies. * Obesity (BMI \>35). * Anemia (\<9 g/dl). * Retained placental tissues. * Big baby (\> 4 kg). * Presence of coagulopathy. * Polyhydramnios. * Presence of Uterine fibroids. * Medical diseases as; cardiac, liver, renal or endocrine diseases. * General anesthesia.

What they're measuring

The rate of postpartum hemorrhage more than 1000 ml

Timeframe: 30 minutes

Trial details

NCT IDNCT04756661

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-31

View on ClinicalTrials.gov More Preeclampsia Severe trials